Alec McDonald

4.3k citations

30 papers · 1.4k indexed · 1 hit paper · h-index 15

Impact in

Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Surgical Treatments
- Inflammatory Biomarkers in Disease Prognosis
Surgery top 5%
- Colorectal and Anal Carcinomas
- Cholangiocarcinoma and Gallbladder Cancer Studies

Papers in

Oncology 26
- Colorectal Cancer Surgical Treatments 11
- Pancreatic and Hepatic Oncology Research 11
- Colorectal Cancer Treatments and Studies 9
- Cancer Treatment and Pharmacology 3
- Inflammatory Biomarkers in Disease Prognosis 3
Cancer Research 8
- Cancer Genomics and Diagnostics 8

Co-authors: Tim Maughan David Sebag‐Montefiore Rob Glynne‐Jones Donald C. McMillan Margaret McKernan Robert C. Stuart Andrew Crumley Stephen Falk
Journals: Journal of Clinical Oncology (8 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)European Journal of Cancer (2 papers)Annals of Oncology (2 papers)The Lancet Oncology (2 papers)
Partner nations: United Kingdom Sweden Germany

In The Last Decade

Alec McDonald

28 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial 2013 · 459 citations

Peers

Countries citing papers authored by Alec McDonald

Since Specialization

Citations

This map shows the geographic impact of Alec McDonald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alec McDonald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alec McDonald more than expected).

Fields of papers citing papers by Alec McDonald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alec McDonald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alec McDonald. The network helps show where Alec McDonald may publish in the future.

Co-authors

The 25 scholars most cited alongside Alec McDonald, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alec McDonald Line = papers co-authored together Alec McDonald links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Synthesis and Characterization of a Sustained Nitric Oxide-Releasing Orthodontic Elastomeric Chain for Antimicrobial Action International Journal of Molecular Sciences ·Alec McDonald, Carly Warden, Jinlian Tan, Kellianne M. Piell, Jill M. Steinbach-Rankins, Nandakumar Janakiraman, David A. Scott, Marsha P. Cole, Sudha Gudhimella	2024	1
2	The neoadjuvant rectal score and a novel magnetic resonance imaging based neoadjuvant rectal score are stage independent predictors of long‐term outcome in locally advanced rectal cancer Colorectal Disease ·Ross K. McMahon, Séan M. O’Cathail, Harikrishnan S Nair, Colin W. Steele, Jonathan Platt, Michael Digby, Alec McDonald, Paul G. Horgan, Campbell S.D. Roxburgh	2023	2
3	The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer Clinical and Translational Radiation Oncology ·Lynsey Devlin, L. Grocutt, Bianca Hunter, H. Chemu, Aileen Duffton, Alec McDonald, Nicholas MacLeod, Philip McLoone, Séan M. O’Cathail	2022	1
4	ESPAC-4 : A Multicenter, International, Randomized Controlled Phase III Trial of Adjuvant Combination Chemotherapy of Gemcitabine (GEM) and Capecitabine (CAP), Versus Monotherapy Gemcitabine in Patients With Resected Pancreatic Ductal Adenocarcinoma Pancreas ·John P. Neoptolemos, D. Palmer, Paula Ghaneh, José Carlos do Valle, David Cunningham, Jonathan Wadsley, Tine Meyer, Alan Anthoney, Bengt Glimelius, S. Falk, P Lind, Jacob R. Izbicki, Gary Middleton, P.J. Ross, Harpreet Wasan, Alec McDonald, T. Crosby, Eftychia Eirini Psarelli, Pascal Hammel, Markus W. Buechler	2016	2
5	O-003 Long-term outcome from the SCALOP trial: a multi-centre randomized phase II trial of gemcitabine or capecitabine-based chemoradiation (CRT) for locally advanced pancreatic cancer (LAPC) Annals of Oncology ·Chris Hurt, John Bridgewater, Stephen Falk, S. Cummins, Harpreet Wasan, Tom Crosby, G. Radhakrishna, Catherine Jephcott, Rajarshi Roy, Alec McDonald, Ruby Ray, Geetha Joseph, John Staffurth, R. A. Abrams, Gareth Griffiths, Tim Maughan, Somnath Mukherjee	2016	6
6	Health-Related Quality of Life in SCALOP, a Randomized Phase 2 Trial Comparing Chemoradiation Therapy Regimens in Locally Advanced Pancreatic Cancer International Journal of Radiation OncologyBiologyPhysics ·Chris Hurt, Somnath Mukherjee, John Bridgewater, Stephen Falk, Tom Crosby, Alec McDonald, George Joseph, John Staffurth, Ross A. Abrams, Jane Blazeby, Sarah Bridges, Peter Dutton, Gareth Griffiths, Tim Maughan, Colin Johnson	2015	22
7	Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial The Lancet Oncology ·Somnath Mukherjee, Chris Hurt, John Bridgewater, Stephen Falk, Sebastian Cummins, Harpreet Wasan, Tom Crosby, Catherine Jephcott, Rajarshi Roy, Ganesh Radhakrishna, Alec McDonald, Ruby Ray, George Joseph, John Staffurth, Ross A. Abrams, Gareth Griffiths, Tim Maughan	2013	249
8	Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial The Lancet Oncology ·R.D. James, Rob Glynne‐Jones, Helen Meadows, David Cunningham, Arthur Sun Myint, Mark Saunders, Tim Maughan, Alec McDonald, Sharadah Essapen, Martin Leslie, Stephen Falk, Charles B. Wilson, Simon Gollins, Rubina Begum, Jonathan A. Ledermann, Latha Kadalayil, David Sebag‐Montefiore Hit paper breakdown →	2013	459
9	HENT1 tumor levels to predict survival of pancreatic ductal adenocarcinoma patients who received adjuvant gemcitabine and adjuvant 5FU on the ESPAC trials. Journal of Clinical Oncology ·John P. Neoptolemos, William Greenhalf, Paula Ghaneh, Daniel H. Palmer, Trevor F. Cox, Elizabeth O. Garner, Fiona Campbell, John R. Mackey, Malcolm J. Moore, Juan W. Valle, Alec McDonald, Niall C. Tebbutt, Christos Dervenis, Bengt Glimelius, Richard Charnley, F Lacaine, Julia Mayerle, Charlotte Rawcliffe, Claudio Bassi, Markus W. Büchler, (unknown)	2013	14
10	Adjuvant chemotherapy for resected colon cancer: comparison of the prognostic value of tumour and patient related factors International Journal of Colorectal Disease ·Campbell S.D. Roxburgh, Alec McDonald, Jonathan Salmond, Karin Oien, John H. Anderson, Ruth F. McKee, Paul G. Horgan, Donald C. McMillan	2011	19
11	A bilateral cicatricial ectropion and bilateral upper lid shortening caused by 5-fluorouracil toxicity in a patient with dihydropyrimidine dehydrogenase deficiency Cutaneous and Ocular Toxicology ·E. Ebube, Alec McDonald, Ewan Kemp	2010	4
12	“Mind the Gap”—The Impact of Variations in the Duration of the Treatment Gap and Overall Treatment Time in the First UK Anal Cancer Trial (ACT I) International Journal of Radiation OncologyBiologyPhysics ·Rob Glynne‐Jones, David Sebag‐Montefiore, Richard Adams, Alec McDonald, Simon Gollins, R.D. James, John Northover, Helen Meadows, Mark Jitlal	2010	40
13	EXTRA—A Multicenter Phase II Study of Chemoradiation Using a 5 Day per Week Oral Regimen of Capecitabine and Intravenous Mitomycin C in Anal Cancer International Journal of Radiation OncologyBiologyPhysics ·Rob Glynne‐Jones, Helen Meadows, Susan Wan, Simon Gollins, Martin Leslie, Ed Levine, Alec McDonald, Sun Myint, Leslie Samuel, David Sebag‐Montefiore	2008	88
14	Combined Modality Treatment of Early Rectal Cancer — the UK Experience Clinical Oncology ·Arthur Sun Myint, Robert Grieve, Alec McDonald, E.L. Levine, Sasirekha Ramani, K. Perkins, Helen Wong, C. A. Makin, M J Hershman	2007	34
15	A nurse-/pharmacy-led capecitabine clinic for colorectal cancer: Results of a prospective audit and retrospective survey of patient experiences European Journal of Oncology Nursing ·Alice MacLeod, Anna Branch, J Cassidy, Alec McDonald, N. Mohammed, Lyndsey Macdonald	2007	31
16	Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer British Journal of Cancer ·Andrew Crumley, Donald C. McMillan, Margaret McKernan, Alec McDonald, Robert C. Stuart	2006	242
17	A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer Annals of Oncology ·Rob Glynne‐Jones, David Sebag‐Montefiore, Tim Maughan, S. Falk, Alec McDonald	2005	68
18	Accuracy of thin section magnetic resonance using phased-array pelvic coil in predicting the T-staging of rectal cancer European Journal of Radiology ·F.W. Poon, Alec McDonald, John H. Anderson, Fraser R. Duthie, C. Rodger, G. McCurrach, Ruth F. McKee, Paul G. Horgan, Alan K. Foulis, D. Chong, I. G. Finlay	2004	28
19	Management of hepatic cysts by percutaneous drainage and instillation of tetracycline hydrochloride. PubMed ·McFarlane Me, Renu Venugopal, Alec McDonald, R Ewing, Newnham Ms, Lynt B. Johnson	2001	2
20	Non-Hodgkin's lymphoma presenting with spinal cord compression; a clinicopathological review of 25 cases European Journal of Cancer ·Alec McDonald, James A. R. Nicoll, R Rampling	2000	37

About Alec McDonald

Alec McDonald is a scholar working on Oncology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Dermatology, having authored 30 papers that have together received 1.4k indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (11 papers), Pancreatic and Hepatic Oncology Research (11 papers), Colorectal Cancer Treatments and Studies (9 papers), Colorectal and Anal Carcinomas (9 papers), Cancer Genomics and Diagnostics (8 papers), Gastric Cancer Management and Outcomes (5 papers), Cancer Treatment and Pharmacology (3 papers) and Inflammatory Biomarkers in Disease Prognosis (3 papers). The work is most often cited by research in Oncology (902 citations), Surgery (855 citations), Pulmonary and Respiratory Medicine (565 citations), Cancer Research (223 citations) and Epidemiology (240 citations). Alec McDonald has collaborated with scholars based in United Kingdom, Sweden and Germany. Frequent co-authors include Tim Maughan, David Sebag‐Montefiore, Rob Glynne‐Jones, Donald C. McMillan, Margaret McKernan, Robert C. Stuart, Andrew Crumley, Stephen Falk, Helen Meadows and Simon Gollins. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, European Journal of Cancer, Annals of Oncology and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact